Skip to main content

EDITORIAL article

Front. Immunol., 12 June 2023
Sec. Comparative Immunology
This article is part of the Research Topic Immunosuppressive disease in poultry View all 5 articles

Editorial: Immunosuppressive disease in poultry

  • 1Animal Bioscience and Biotechnology Laboratory, Beltsville Agricultural Research Center, Agricultural Research Service, United States Department of Agriculture, Beltsville, MD, United States
  • 2Veterinary Diagnostic Laboratory, Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois, Urbana, IL, United States
  • 3College of Veterinary Medicine, China Agricultural University, Beijing, China

Editorial on the Research Topic
Immunosuppressive disease in poultry

Immunosuppression, originally defined as “a state of temporary or permanent dysfunction of the immune response resulting from damage to the immune system and leading to increased susceptibility to disease” (1), includes suboptimal responses in antibody production, innate and cellular immunities. Immunosuppressive diseases can increase susceptibility to infections and mortalities, reduce feed conversion and vaccine effectiveness, and influence condemnation at processing and total production cost. As a result, they have substantial negative impacts on poultry health and welfare, and production performance in the global poultry industry. Understanding of the pathogenesis of immunosuppressive diseases is crucial to safeguarding health and productivity in the poultry industry.

This Research Topic aims to collect contributions on progresses made in understanding avian immunosuppressive diseases, especially virus-mediated immunosuppression and immunoevasion, persistent infection, pathogen-host interactions, innate immune response, signal transduction, cytokine expressions, and the roles of microRNAs in host antidefense response. It also aims to highlight challenges and opportunities for future research in novel vaccine development, diagnosis, and control of avian immunosuppressive diseases.

With advanced technologies in gene sequencing and the availability of avian immunoreagents, scientists may have more tools in deciphering the pathogenesis of immunosuppressive inducers such as infectious pathogens, and environmental and nutritional/social stressors. This Research Topic keeps readers up-to-date with new insights and advanced knowledge on hosts, interactions between hosts and immunosuppressive pathogens, mechanisms of immunoevasion, and vaccine development in the prevention and control of infectious diseases.

We received eight submissions, and four were published in this Research Topic, including one review focused on the avian leucosis virus-host interaction, one review on the advances of innate immunoevasion by avian immunosuppressive viruses, one original research on the effect of host major histocompatibility complex on pathogenesis and tumorigenesis, and another original research on parasite vaccines in promotion of host responses. This editorial summary highlights these four recent articles published in Frontiers in Immunology that shed light on the mechanisms of immunosuppression in poultry and potential avenues for the prevention and treatment of infectious diseases.

Viruses, including Infectious Bursal Disease Virus (IBDV), Chicken Infectious Anemia Virus (CIAV), Marek’s Disease Virus (MDV) and Avian Leukosis Virus (ALV), are the major immunosuppressive inducers. They can cause apoptosis and/or necrosis of lymphoid cells and induce the malfunction of immune response regulation (2). Among them, ALV is known to initiate diseases correlated with tumor formation and decreased fertility, and induces severe immunosuppression by increasing host vulnerability to other microbial infections and the risk of failure in subsequent vaccination against other diseases. ALV is difficult to control because there is currently no effective vaccine available, and control measures typically involve culling infected birds and strict biosecurity measures to prevent the spread of the virus. Tang et al. reviewed the involvement of host factors in the important molecular events during ALV infection. They revealed the cellular receptors associated with ALV viral entry and displayed how the host’s innate and adaptive immune responses are involved during ALV infection. The authors presented that cellular factors, such as non-coding RNAs and cellular proteins/signaling pathways, were associated with viral replication. They discussed the future perspectives in the development of effective antiviral strategies in chickens.

Innate immunity is the host’s first line of defense against invading pathogens, but some pathogens, particularly immunosuppressive viruses, have evolved sophisticated mechanisms to evade the host’s innate immune responses and survive within the host. Wang et al. reviewed avian immunosuppressive viruses and their evolutionary strategies for evading the innate immune system. The authors identified several viral proteins that interacted with host cellular proteins or regulate microRNA expression to interfere with various components of the innate immune system, such as Toll-like receptors, IFN-I signal transduction, autophagy, apoptosis, necrosis, inflammasome, and metabolic pathways. The review emphasized the importance of understanding of these complex evasion or suppression mechanisms to develop effective antiviral strategies for chickens.

Major histocompatibility complex (MHC)-encoded class I and class II molecules are crucial for mounting specific and optimal adaptive immune responses, particularly in developing vaccinal immunity, and are typically highly polymorphic and polygenic (3). Bertzbach et al. investigated the role of diverse MHC haplotypes in MDV pathogenesis and tumorigenesis in chickens. MDV is a herpesvirus that causes lymphoid hyperplasia and lymphoma, leading to early cytolytic infection of B cells and transformation of T cells, and eventually immunosuppression in infected chickens. The authors found that chickens with certain MHC haplotypes were more genetically susceptible to MDV infection and tumorigenesis than others. The article suggests that breeding for specific MHC haplotypes could decrease the incidence of MDV in poultry flocks.

Coccidian species are a subclass of obligate intracellular protozoan parasites belonging to the apicomplexan class, among which two groups, Cryptosporidium baileyi and Eimeria species, have been linked to immuno-suppression, although with limited evidence (2). Eimeria spp. can cause coccidiosis, a major enteric infectious disease in broiler chickens in the US, resulting in significant economic losses of approximately $12 billion annually in the global poultry industry. Coccidiosis is also a predisposing factor for necrotic enteritis. Chen et al. described an EmARM-β antigen from Eimeria maxima, and found that vaccination with recombinant EmARM-β antigen or a plasmid carrying this gene effectively stimulated the expression of Th1 cytokines (IL-2 and IFN-γ), promoted the proportion of CD4+ and CD8+ T cells and the level of antigen-specific IgG antibodies in immunized chickens, and conferred moderate protective efficacy against E. maxima (alleviated weight loss and enteric lesion, reduced oocyst output, and higher anticoccidial index in challenged birds). The authors suggested that this antigen could be a promising candidate for developing a new vaccine against coccidiosis.

Finally, we extend our heartfelt appreciation to the authors who generously shared their original work with us for this Research Topic. We are also grateful to the reviewers who provided us with their insightful comments and helped enhance the quality of the submissions. Our sincere thanks go to the editorial office of Frontiers in Immunology for their exceptional support throughout the process, enabling us to successfully host this Research Topic.

Author contributions

CL and SZ drafted the manuscript. LW revised it. All authors approved the final version for publication.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Dohms JE, Saif YM. Criteria for evaluating immunosuppression. Avian Dis (1984) 28:305–10. doi: 10.2307/1590336

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Schat K, Skinner MA. Vian immunosuppressive diseases and immunoevasion. Avian Immunol (second edition) Academic Press (2014), 275–97. doi: 10.1016/B978-0-12-396965-1.00016-9

CrossRef Full Text | Google Scholar

3. Miller M, Taylor RL Jr. Brief review of the chicken major histocompatibility complex: the genes, their distribution on chromosome 16, and their contributions to disease resistance. Poultry Sci (2016) 95:375–92. doi: 10.3382/ps/pev379

CrossRef Full Text | Google Scholar

Keywords: immunosuppressive diseases, immunoevasion, poultry, virus, Eimeria, major histocompatibility complex

Citation: Li C, Wang L and Zheng S (2023) Editorial: Immunosuppressive disease in poultry. Front. Immunol. 14:1215513. doi: 10.3389/fimmu.2023.1215513

Received: 02 May 2023; Accepted: 26 May 2023;
Published: 12 June 2023.

Edited and Reviewed by:

Christi Swaggerty, Agricultural Research Service (USDA), United States

Copyright © 2023 Li, Wang and Zheng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Charles Li, charles.li@ars.usda.gov; Shijun Zheng, sjzheng@cau.edu.cn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.